JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan
· Delayed Price · Currency is JPY 630.00
+20.00 (3.28%)
Mar 10, 2026, 11:30 AM JST
JCR Pharmaceuticals Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 15,643 | 13,196 | 18,756 | 13,278 | 30,733 | 26,260 | Upgrade
|
| Short-Term Investments | - | - | - | - | 244 | - | Upgrade
|
| Cash & Short-Term Investments | 15,643 | 13,196 | 18,756 | 13,278 | 30,977 | 26,260 | Upgrade
|
| Cash Growth | 0.84% | -29.64% | 41.26% | -57.14% | 17.96% | 134.61% | Upgrade
|
| Receivables | 14,829 | 12,236 | 14,934 | 11,137 | 15,585 | 8,183 | Upgrade
|
| Inventory | 24,903 | 21,758 | 20,933 | 18,514 | 14,636 | 13,554 | Upgrade
|
| Other Current Assets | 3,144 | 3,866 | 2,958 | 4,873 | 990 | 548 | Upgrade
|
| Total Current Assets | 58,519 | 51,056 | 57,581 | 47,802 | 62,188 | 48,545 | Upgrade
|
| Property, Plant & Equipment | 39,679 | 37,410 | 30,040 | 32,681 | 26,782 | 17,172 | Upgrade
|
| Long-Term Investments | 9,383 | 10,442 | 9,819 | 9,443 | 2,769 | 3,094 | Upgrade
|
| Other Intangible Assets | 2,628 | 2,960 | 3,496 | 3,652 | 2,960 | 3,232 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 2,985 | 1,288 | 1,357 | 2,433 | 1,739 | Upgrade
|
| Other Long-Term Assets | 3,097 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Total Assets | 113,306 | 104,855 | 102,226 | 94,937 | 97,134 | 73,784 | Upgrade
|
| Accounts Payable | 1,676 | 590 | 890 | 1,563 | 1,324 | 2,932 | Upgrade
|
| Accrued Expenses | 712 | 1,216 | 1,130 | 1,088 | 1,004 | 913 | Upgrade
|
| Short-Term Debt | 37,762 | 23,005 | 8,950 | 16,800 | 15,150 | 12,850 | Upgrade
|
| Current Portion of Long-Term Debt | - | 3,050 | - | 500 | - | - | Upgrade
|
| Current Income Taxes Payable | 197 | 3,097 | 4,402 | 2,836 | 11,104 | 2,646 | Upgrade
|
| Other Current Liabilities | 9,978 | 13,030 | 14,763 | 12,975 | 13,472 | 9,687 | Upgrade
|
| Total Current Liabilities | 50,325 | 43,988 | 30,135 | 35,762 | 42,054 | 29,028 | Upgrade
|
| Long-Term Debt | 14,850 | 12,050 | 14,350 | 5,500 | 2,950 | 5,250 | Upgrade
|
| Pension & Post-Retirement Benefits | 1,016 | 966 | 903 | 924 | 870 | 798 | Upgrade
|
| Other Long-Term Liabilities | 368 | 418 | 364 | 339 | 173 | 154 | Upgrade
|
| Total Liabilities | 66,559 | 57,422 | 45,752 | 42,525 | 46,047 | 35,230 | Upgrade
|
| Common Stock | 9,061 | 9,061 | 9,061 | 9,061 | 9,061 | 9,061 | Upgrade
|
| Additional Paid-In Capital | 10,378 | 10,392 | 10,384 | 10,384 | 10,994 | 10,941 | Upgrade
|
| Retained Earnings | 30,492 | 31,191 | 37,278 | 34,273 | 33,241 | 20,904 | Upgrade
|
| Treasury Stock | -4,974 | -5,066 | -2,963 | -2,978 | -3,600 | -3,685 | Upgrade
|
| Comprehensive Income & Other | 1,365 | 1,463 | 2,417 | 1,421 | 1,186 | 1,159 | Upgrade
|
| Total Common Equity | 46,322 | 47,041 | 56,177 | 52,161 | 50,882 | 38,380 | Upgrade
|
| Minority Interest | 425 | 392 | 297 | 251 | 205 | 174 | Upgrade
|
| Shareholders' Equity | 46,747 | 47,433 | 56,474 | 52,412 | 51,087 | 38,554 | Upgrade
|
| Total Liabilities & Equity | 113,306 | 104,855 | 102,226 | 94,937 | 97,134 | 73,784 | Upgrade
|
| Total Debt | 52,612 | 38,105 | 23,300 | 22,800 | 18,100 | 18,100 | Upgrade
|
| Net Cash (Debt) | -36,969 | -24,909 | -4,544 | -9,522 | 12,877 | 8,160 | Upgrade
|
| Net Cash Growth | - | - | - | - | 57.81% | 234.97% | Upgrade
|
| Net Cash Per Share | -303.14 | -201.16 | -36.24 | -76.27 | 103.67 | 65.74 | Upgrade
|
| Filing Date Shares Outstanding | 121.99 | 121.84 | 124.8 | 124.78 | 123.76 | 123.61 | Upgrade
|
| Total Common Shares Outstanding | 121.99 | 121.84 | 124.8 | 124.78 | 123.76 | 123.61 | Upgrade
|
| Working Capital | 8,194 | 7,068 | 27,446 | 12,040 | 20,134 | 19,517 | Upgrade
|
| Book Value Per Share | 379.73 | 386.10 | 450.12 | 418.04 | 411.14 | 310.48 | Upgrade
|
| Tangible Book Value | 43,694 | 44,081 | 52,681 | 48,509 | 47,922 | 35,148 | Upgrade
|
| Tangible Book Value Per Share | 358.19 | 361.81 | 422.11 | 388.77 | 387.23 | 284.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.